Patent details

EP2951205 Title: ANTI-ACTIVIN-A COMPOUNDS FOR THE TREATMENT OF OVARIAN CANCER

Basic Information

Publication number:
EP2951205
PCT Application Number:
US2014014490
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147461149
PCT Publication Number:
WO2014121221
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-ACTIVIN-A COMPOUNDS FOR THE TREATMENT OF OVARIAN CANCER
French Title of Invention:
COMPOSÉS ANTI-ACTIVINE POUR LE TRAITEMENT DU CANCER DES OVAIRES
German Title of Invention:
ANTI-AKTIVIN-A-VERBINDUNGEN ZUR BEHANDLUNG VOM OVARIALKREBS
SPC Number:

Dates

Filing date:
03/02/2014
Grant date:
11/08/2021
EP Publication Date:
09/12/2015
PCT Publication Date:
07/08/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/08/2021
EP B1 Publication Date:
11/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/02/2022
Expiration date:
03/02/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/11/2021
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, California 91320, United States (US)

Name:
Atara Biotherapeutics, Inc.
Address:
611 Gateway Blvd. Suite 900, South San Francisco, CA 94080, United States (US)

History of Owners

From:
04/08/2021
To:
05/11/2021

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, California 91320, United States (US)

Name:
Santa Maria Biotherapeutics, Inc.
Address:
701 Gateway Blvd., Suite 200, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:
CIECHANOVER, Isaac
Address:
United States (US)

2

Name:
ZHOU, Xiaolan
Address:
United States (US)

3

Name:
HAQQ, Christopher, Michael
Address:
United States (US)

4

Name:
HAN, Huiquan
Address:
United States (US)

5

Name:
LU, John, Zhao-nian
Address:
United States (US)

Priority

1

Priority Number:
201361759961 P
Priority Date:
01/02/2013
Priority Country:
United States (US)

2

Priority Number:
201361815220 P
Priority Date:
23/04/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 47/68; A61K 38/17; C07K 16/26; C07K 16/00; A61K 31/395; A61K 39/00; A61K 31/704; A61K 31/7068; A61K 39/395; A61K 45/06; C07K 16/22;

Publication

European Patent Bulletin

1

Issue number:
202132
Publication date:
11/08/2021
Description:
Grant (B1)

2

Issue number:
202137
Publication date:
15/09/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202149
Publication date:
08/12/2021
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages